
INFIQ
Healthcare · Biotechnology · $908 market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2023
EPS trend, 90 days to now · 30-day revisions 1 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 13, 2025 | Time not confirmed | — | 0.00 | — |
| May 30, 2025 | Time not confirmed | — | 0.00 | — |
| Mar 26, 2025 | Time not confirmed | -0.15 | -0.11 | +26.7% |
| Nov 29, 2024 | Time not confirmed | -0.14 | 0.00 | +100.0% |
| Aug 7, 2024 | Time not confirmed | -0.13 | 0.00 | +100.0% |
| May 1, 2024 | Time not confirmed | -0.13 | 0.00 | +100.0% |
| Mar 14, 2024 | Time not confirmed | -0.12 | 0.00 | +100.0% |
| Nov 1, 2023 | Time not confirmed | -0.12 | 0.00 | +100.0% |
| Aug 8, 2023 | Time not confirmed | -0.12 | -0.11 | +7.7% |
| May 9, 2023 | Time not confirmed | -0.11 | -0.11 | 0.0% |
| Mar 28, 2023 | Time not confirmed | -0.11 | -0.11 | 0.0% |
| Nov 14, 2022 | Time not confirmed | -0.12 | -0.12 | 0.0% |
| Aug 9, 2022 | Time not confirmed | -0.13 |
Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative…
| -0.13 |
| 0.0% |
| May 3, 2022 | Time not confirmed | -0.14 | -0.14 | 0.0% |
| Mar 29, 2022 | Time not confirmed | -0.13 | -0.13 | 0.0% |
| Nov 2, 2021 | Time not confirmed | -0.12 | -0.12 | 0.0% |
| Jul 27, 2021 | Time not confirmed | -0.13 | -0.13 | 0.0% |
| May 13, 2021 | Time not confirmed | -0.15 | -0.15 | 0.0% |
| Mar 16, 2021 | Time not confirmed | -0.17 | -0.17 | 0.0% |
| Nov 9, 2020 | Time not confirmed | -0.16 | -0.16 | 0.0% |
| Jul 30, 2020 | Time not confirmed | -0.16 | -0.16 | 0.0% |
| May 11, 2020 | Time not confirmed | -0.19 | -0.19 | 0.0% |
| Mar 3, 2020 | Time not confirmed | -0.21 | -0.21 | 0.0% |
| Oct 30, 2019 | Time not confirmed | -0.20 | -0.20 | 0.0% |
| Jul 30, 2019 | Time not confirmed | -0.18 | -0.18 | 0.0% |
| May 7, 2019 | Time not confirmed | -0.05 | -0.24 | -380.0% |
| Mar 14, 2019 | Time not confirmed | -0.17 | -0.13 | +23.5% |
| Nov 5, 2018 | Time not confirmed | -0.14 | 0.23 | +264.3% |
| Aug 7, 2018 | Time not confirmed | -0.20 | -0.12 | +40.0% |
| May 8, 2018 | Time not confirmed | -0.18 | -0.18 | 0.0% |
| Mar 15, 2018 | Time not confirmed | -0.25 | -0.14 | +44.0% |